Tag Archives: prostate

Soy against 2 cancer, prostate and breast cancer

In addition to flavor our food, soy may also help in the battle against two types of cancer: the breast and the prostate. To detect the two studies were reported by British newspaper the Daily Mail. The first ‘was conducted by a team of researchers at the University of Chicago Northwestern. The results ‘showed that one pill a day of’ genistein ‘, the main isoflavone found in soy, and’ able to slow or stop the spread of prostate cancer.

Although the study involved a small sample of 38 men, scientists believe that these results could lead to the first non-toxic treatment that prevents the movement of cancer cells.

“The first step – said Raymond Bergan, who led the study – and ‘was to see if the drug has the desired effect on the cells and the prostate, and the answer’ it was ‘. If this drug can’ effectively prevent prostate cancer can spread throughout the body, such therapy could theoretically have the same effect on the cells of other types of cancer. “

The second study ‘pro-soy’ and ‘was conducted by the University’ of Buffalo (New York) and involved nearly 1,300 women. The results’ showed that soy isoflavones may reduce the risk of developing breast cancer. Researchers have found that women who consumed more ‘isoflavones have a 30 percent chance’ to be less affected by invasive breast cancer and 60 per cent chance ‘in less than developing cancer’ low degree ‘.

To arrive at these conclusions, the scientists compared the data of 683 women with breast cancer with 611 healthy women. “We have definitely seen – said Anne Weaver, who led the study – a reduction (risk) that deserves further investigation.”

Leave a comment

Posted by on January 17, 2011 in cancer news


Tags: , , , , ,

Prostate cancer screening

By Dr. Gino Carpinito, Chairman, Department of Urology, Tufts Medical Center

The Prostate Cancer Education Council recommends that men age 40 and older begin screening for prostate cancer. Men at high risk like African-American men or men with a family history of prostate cancer should begin screening at age 35.

Since the late 1980’s when prostate screening with the PSA began, the 5 year survival rate for men with prostate cancer has risen dramatically from 75% to over 99%.

The prostate gland is a part of the male reproductive system. The prostate is about the size of a walnut and is located below the bladder and in front of the rectum. The prostate surrounds the urethra, the canal that the urine passes through as it moves from the bladder during urination. The main function of the prostate is to produce the liquid part of semen necessary for ejaculation and sperm function.

Prostate cancer is an uncontrolled growth of abnormal cells in the prostate gland. Most prostate cancers usually grow slowly, however some cancers can grow rapidly and spread outside the prostate gland. Prostate cancer usually has no signs or symptoms, especially in its earliest stages. However, once the cancer has grown, it may cause discomfort and a variety of other symptoms.

Below are a few of the many reasons why it is so important to be screened for prostate cancer:
• 1 in 6 American men will get prostate cancer in their lifetime.
• Over 30,000 men will needlessly die of prostate cancer this year alone.
• A man is 33% more likely to get prostate cancer than a woman is to get breast cancer.
• Chances of survival improve substantially with early diagnosis and treatment.
• If diagnosed and treated early, survival rates are nearly 100%.
• The best protection against lethal advanced prostate cancer is early detection.

A digital rectal exam (DRE) performed together with the prostate specific antigen (PSA) blood test is the most effective way to detect prostate cancer at an early and likely curable state. PSA is produced by both normal and cancerous prostate cells and is measured in a blood sample. The higher the PSA level, the greater the chance a man has prostate cancer. Elevated PSA tests are usually followed by an ultrasound and a biopsy to determine whether cancer is present and, if so, its level of development. Both DRE and PSA tests are preformed during prostate cancer screening.

Treatment options depend on the stage of the disease, patient’s age, physician’s recommendation and personal decision. Some prostate cancers may never affect a patient’s health and are better left untreated to avoid potential complications of treatment. Such cancers are managed by a conservative approached known as “Watchful waiting”, when the patient is closely observed by his physician, but no active treatment is undertaken.

The first course of action for treating the disease includes, but is not limited to:
• Surgery (Radical Prostatectomy)
• Radiation Therapy
• Hormone Therapy (Advanced cancer)
• Chemotherapy (Advanced cancer)


Testing for prostate cancer is a personal decision that should be made by each man in consultation with his physician. The advantages of screening were discussed above. Some disadvantages of early detection should be also considered, such as false-positive results. These are infrequent, but cause unnecessary anxiety and have to be ruled out by additional tests such as prostate biopsies. Large research studies are ongoing to study benefits and shortcomings of early prostate cancer detection and treatment.

For an appointment with the Tufts Urology Clinic please call 617/636-6317.

Article funded through the Asian Health Initiative of Tufts Medical Center

Leave a comment

Posted by on October 10, 2009 in cancer news


Tags: , , ,